{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:30:08Z","timestamp":1786570208483,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ogla.2026.06.010","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:59:00Z","timestamp":1782230340000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Intraocular Pressure Control on Visual Field Progression in the HORIZON Trial"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9148-2804","authenticated-orcid":false,"given":"Giovanni","family":"Montesano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ometto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqbal","family":"Ike K.Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gus","family":"Gazzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2026.06.010_bib1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","article-title":"Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial","volume":"385","author":"Garway-Heath","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ogla.2026.06.010_bib2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2026.06.010_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.06.010_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","article-title":"Visual field progression in the collaborative initial glaucoma treatment study","volume":"116","author":"Musch","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.06.010_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ophtha.2024.01.007","article-title":"Evaluating primary treatment for people with advanced glaucoma: five-year results of the treatment of advanced glaucoma study","volume":"131","author":"King","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","article-title":"Laser in glaucoma and ocular hypertension (LiGHT) trial","volume":"130","author":"Gazzard","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ajo.2007.06.012","article-title":"Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use","volume":"144","author":"Robin","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.06.010_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ceo.12888","article-title":"Minimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma","volume":"45","author":"Kerr","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ogla.2026.06.010_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ophtha.2024.07.030","article-title":"Special commentary: reporting clinical endpoints in studies of minimally invasive glaucoma surgery","volume":"132","author":"Gedde","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib11","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.ophtha.2024.10.002","article-title":"Re: Gedde et al: special Commentary: reporting clinical endpoints in studies of minimally invasive glaucoma surgery (Ophthalmology. 2025;132:141-153)","volume":"132","author":"Rabiolo","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ophtha.2022.02.021","article-title":"Long-term outcomes from the HORIZON randomized trial for a Schlemm\u2019s canal microstent in combination cataract and glaucoma surgery","volume":"129","author":"Ahmed","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ogla.2024.02.004","article-title":"Prospective, randomized controlled trial of cataract surgery vs combined cataract surgery with insertion of iStent inject","volume":"7","author":"Fan Gaskin","year":"2024","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2026.06.010_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ogla.2025.04.005","article-title":"Disease progression, not intraocular pressure, should guide escalation of treatment in glaucoma","volume":"8","author":"Montesano","year":"2025","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2026.06.010_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ophtha.2018.05.012","article-title":"A Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON study","volume":"126","author":"Samuelson","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ophtha.2020.11.004","article-title":"Three-year findings of the HORIZON trial: a schlemm canal microstent for pressure reduction in primary open-angle glaucoma and cataract","volume":"128","author":"Ahmed","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajo.2023.02.008","article-title":"Five-year visual field outcomes of the HORIZON trial","volume":"251","author":"Montesano","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.06.010_bib18","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.ophtha.2020.01.025","article-title":"Effect of a Schlemm\u2019s canal microstent on early postoperative intraocular pressure after cataract surgery: an analysis of the HORIZON randomized controlled trial","volume":"127","author":"Zebardast","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/tvst.13.4.15","article-title":"Estimating the distribution of true rates of visual field progression in glaucoma","volume":"13","author":"Montesano","year":"2024","journal-title":"Trans Vis Sci Technol"},{"key":"10.1016\/j.ogla.2026.06.010_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1167\/iovs.66.1.32","article-title":"Relationship between intraocular pressure and the true rate of functional and structural progression in the United Kingdom glaucoma treatment study","volume":"66","author":"Montesano","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2026.06.010_bib21","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.ophtha.2017.04.035","article-title":"Evidence-based criteria for assessment of visual field reliability","volume":"124","author":"Yohannan","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/13.4.10","article-title":"The visualFields package: a tool for analysis and visualization of visual fields","volume":"13","author":"Marin-Franch","year":"2013","journal-title":"J Vis"},{"key":"10.1016\/j.ogla.2026.06.010_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1214\/ss\/1177011136","article-title":"Inference from iterative simulation using multiple sequences","volume":"7","author":"Gelman","year":"1992","journal-title":"Stat Sci"},{"key":"10.1016\/j.ogla.2026.06.010_bib24","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3389\/fpsyg.2019.02767","article-title":"Indices of effect existence and significance in the Bayesian framework","volume":"10","author":"Makowski","year":"2019","journal-title":"Front Psychol"},{"key":"10.1016\/j.ogla.2026.06.010_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajo.2022.09.011","article-title":"Two-year visual field outcomes of the treatment of advanced glaucoma study (TAGS)","volume":"246","author":"Montesano","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.06.010_bib26","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/OPX.0b013e31818b9b40","article-title":"Is there evidence for continued learning over multiple years in perimetry?","volume":"85","author":"Gardiner","year":"2008","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ogla.2026.06.010_bib27","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1167\/iovs.14-16329","article-title":"Estimating the true distribution of visual field progression rates in glaucoma","volume":"56","author":"Anderson","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2026.06.010_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2025.09.023","article-title":"Six-year rate of visual field progression in the laser in glaucoma and ocular hypertension (LiGHT) trial","volume":"133","author":"Montesano","year":"2026","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajo.2019.01.019","article-title":"Cataract surgery and rate of visual field progression in primary open-angle glaucoma","volume":"201","author":"Kim","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.06.010_bib30","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1167\/iovs.11-8639","article-title":"Incorporating risk factors to improve the assessment of rates of glaucomatous progression","volume":"53","author":"Medeiros","year":"2012","journal-title":"Invest Opthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2026.06.010_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9890831","article-title":"Twenty-four-hour contact lens sensor monitoring of aqueous humor dynamics in surgically or medically treated glaucoma patients","volume":"2019","author":"Posarelli","year":"2019","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.ogla.2026.06.010_bib32","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ophtha.2020.03.029","article-title":"Visual field outcomes from the multicenter, randomized controlled laser in glaucoma and ocular hypertension trial (LiGHT)","volume":"127","author":"Wright","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2006.07.060","article-title":"Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial","volume":"114","author":"Bengtsson","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib34","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ophtha.2024.02.008","article-title":"Relationship between intraocular pressure fluctuation and visual field progression rates in the United Kingdom glaucoma treatment study","volume":"131","author":"Rabiolo","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2026.06.010_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ophtha.2004.10.034","article-title":"The low-pressure glaucoma treatment study (LoGTS) study design and baseline characteristics of enrolled patients","volume":"112","author":"Krupin","year":"2005","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419626001031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419626001031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T20:55:25Z","timestamp":1786568125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589419626001031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"alternative-id":["S2589419626001031"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2026.06.010","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Intraocular Pressure Control on Visual Field Progression in the HORIZON Trial","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2026.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}